Copyright
©The Author(s) 2019.
World J Clin Cases. Mar 26, 2019; 7(6): 705-716
Published online Mar 26, 2019. doi: 10.12998/wjcc.v7.i6.705
Published online Mar 26, 2019. doi: 10.12998/wjcc.v7.i6.705
Figure 1 Diagnostic algorithm of drug reaction, eosinophilia, and systemic symptoms syndrome / drug-induced hypersensitivity syndrome case series.
ALT: Alanine aminotransaminase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; BALP: Broncho-alveolar lavage fluid; BG: Blood gasses; cB: Conjugated bilirubin; cdefects: Conduction defects; CPK: Creatine phosphokinase; CPK-2/MB: Creatine phosphokinase for heart muscle involvement; CPK-3/CPK-MM: Creatine phosphokinase for skeletal muscle involvement; creaCl: Creatinine clearance; CT: Computed tomography; CXR: Chest-x-ray; ECG: Electrocardiogram; ECHO: Echocardiogram; EMG: Electromyography; EM: Endomyocardial; HP: Histopathology; MRI; TB: Total bilirubin; UNL: Upper normal limit. 1The RegiSCAR criteria should be done to potential cases of DReSS for more accurate diagnosis and classification (see Table 1). 2Organ involvement after exclusion of other explanations.
- Citation: Martinez-Cabriales SA, Shear NH, Gonzalez-Moreno EI. Liver involvement in the drug reaction, eosinophilia, and systemic symptoms syndrome. World J Clin Cases 2019; 7(6): 705-716
- URL: https://www.wjgnet.com/2307-8960/full/v7/i6/705.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i6.705